DoW Toxic Exposures Translational Research Award
🏛 Defense Health Agency Contracting Activity - DHACA (DOD-AMRAA)
✓ Free, no account · Source: Grants.gov · Last verified Oct 30, 2026
Can you apply?
This grant is for researchers translating military-related toxic exposure findings into clinical applications. Eligible applicants are researchers with academic credentials and institutional affiliation, including clinicians, basic scientists, and interdisciplinary teams. The research must address toxic exposures relevant to military personnel and move findings from laboratory to clinical practice. U.S. institutions with strong research infrastructure are preferred.
Not the right fit? Find grants for your organization in 5 questions →
Key dates
- May 21, 2026 Applications open
- Nov 19, 2026 Application deadline in 19 days
- Sep 30, 2027 Award announced
- Sep 30, 2027 Project start
Program description
Summary: The intent of the fiscal year 2026 (FY26) Toxic Exposures Research Program (TERP) Translational Research Award (TRA) is to support translational research that will accelerate the movement of promising ideas in military-related toxic exposure research into clinical applications, including health care products, interventions, technologies and/or clinical practice guidelines. Translational research may be defined as an integration of basic science and clinical observations. New Approach Methodologies may also be used. Applications should provide evidence for the reciprocal transfer of information between basic and clinical science, or vice versa, in developing and implementing the research plan.
Distinctive Features: To encourage applications that include meaningful and productive collaborations, the FY26 TERP TRA includes a Partnering Principal Investigator Option (PPIO). One Principal Investigator (PI) is identified as the initiating PI, and an additional PI may be identified as a Partnering PI. If recommended for funding, each PI will be named on separate awards. The intent is to support interdisciplinary partnerships, such as those between clinicians and research scientists, that will accelerate the movement of promising ideas into clinical applications. Partnering should significantly advance the research beyond what would be possible through individual efforts.
Who can apply
Eligible applicants
Demographic focus
How to apply
Application links
Key dates & requirements
Required documents
- SF-424 (Application for Federal Assistance)
- Project narrative with translational research plan
- Budget and budget justification
- Biographical sketches of all PIs
- Letters of institutional support
- Preliminary data and supporting documentation
Program contact
- 👤 Ebony S Simmons Grantor
- 📧 help@eBRAP.org
- 📞 301-619-2105
Funding track record
Recent awards under CFDA 12.420 from the last 3 years — real organizations that won funding through this same program.
Top 10 Largest Recent Awards
-
$2,265,729,366
-
$800,456,231
-
$77,591,450
-
$74,531,880
-
$55,949,967
-
$34,191,124
-
$24,783,894
-
$21,394,379
-
$19,100,256
-
$19,002,641
Top States by Funding
- MD 10 awards $3,149.9M
- NC 11 awards $132.3M
- CA 14 awards $121.2M
- MA 12 awards $110.3M
- FL 8 awards $99.8M
Source: USAspending.gov — federal spending transparency. Data covers last 3 years.
Funding history
Annual funding for this program — Federal obligations (CFDA 12.420). How funding has trended year over year.
| 2024 | $1,483,968,520 | |
| 2025 | $1,201,153,417 |
FAQ
Who can apply for this grant?
Researchers with doctoral degrees and institutional affiliation can apply. The program encourages partnerships between clinicians and basic scientists.
What is the deadline?
The deadline is November 19, 2026. This is a fixed deadline with no rolling acceptance.
What types of research are supported?
Translational research that moves toxic exposure discoveries from lab to clinical practice. This includes interventions, technologies, health products, and clinical guidelines.
Can multiple researchers lead one project?
Yes. The Partnering Principal Investigator Option allows two PIs on one project, each receiving separate awards if funded.
How competitive is this funding?
The program is highly competitive. The $6M funding pool serves many applications, so strong preliminary data and clear translational pathway are essential.
💡 Tips for applicants
- Emphasize the translational bridge between your basic science and clinical application. Show how each phase informs the next.
- If using the Partnering PI option, demonstrate that collaboration significantly strengthens the research beyond solo efforts.
- Address military-relevant toxic exposures explicitly. Explain how your work benefits military personnel health outcomes.
- Include preliminary data showing feasibility of your translational approach. Reviewers want evidence the idea can move forward.
- Align your project timeline with realistic milestones for moving from research to clinical implementation.
⚠️ Common mistakes
Weak translational links between basic and clinical components; insufficient preliminary data supporting feasibility. Unclear connection to military personnel health or toxic exposures of military relevance.
Similar grants
- OPEN DoW Toxic Exposures Clinical Trial Award — Defense Health Agency Contracting Activity - DHACA
- OPEN DoW Toxic Exposures Investigator Initiated Research Award — Defense Health Agency Contracting Activity - DHACA
- OPEN DoW Spinal Cord Injury, Translational Research Award — Defense Health Agency Contracting Activity - DHACA
- OPEN DoW Vision, Translational Research Award — Defense Health Agency Contracting Activity - DHACA
- OPEN DOW Combat Readiness – Medical Research Program Translational Research Award — Defense Health Agency Contracting Activity - DHACA